We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Mobile Health, Big Data, Antimicrobial Resistance Central to 2014 Meeting

By LabMedica International staff writers
Posted on 29 Jul 2014
Print article
The 2014 American Association of Clinical Chemistry (AACC; Washington DC, USA) annual meeting & clinical lab expo, which is taking place in Chicago (IL, USA) from July 27-31, 2014, focuses on mobile health, big data, and antimicrobial resistance, among many other major healthcare topics.

The meeting and clinical expo is expected to draw more than 17,500 attendees, including prominent leaders in medicine and healthcare, to Chicago’s McCormick Place. Six hundred fifty exhibitors will also introduce more than 200 new diagnostic products, making this one of the 10 largest medical exhibitions in the US.

Mobile health: digital health guru Eric Topol, MD, will deliver the keynote lecture on how mobile technology and the internet are transforming healthcare. A symposium will cover how lab-on-a-chip technology can combat illegal designer drugs, and will look at two experimental technologies that could be the future of illicit drug testing: a point-of-care volumetric bar-chart chip and a miniaturized mass spectrometry device.

Big data: Monday’s plenary speaker Viktor Mayer-Schönberger, coauthor of Big Data: A Revolution That Will Transform How We Live, Work, and Think, will explore how the medical world can harness the massive amounts of data generated by genomic, proteomic, and metabolomic analyses to create new diagnostic tests and disease treatments.

Infectious diseases: The World Health Organization (WHO; Geneva, Switzerland) found that microbial drug resistance has become a serious public health threat worldwide. This is a troubling trend that the short course “Hot Topics in Clinical Microbiology” will examine. Two other sessions will also focus on MALDI-TOF MS, a rising diagnostic technology that is poised to replace standard infectious disease testing techniques—some of which date back to the 1800s—and that could become an important weapon in the fight against antimicrobial resistance.

Diagnostic innovations: from smart phone-based diagnostic readers, to biochips with the potential to diagnose human immunodeficiency virus (HIV), to the first human papilloma virus (HPV) test approved for primary cervical cancer screening. The latest diagnostic technology in mobile health, infectious diseases, reproductive health, and more will also be displayed at the AACC Clinical Lab Expo.

At the 2014 AACC Annual Meeting & Clinical Lab Expo plenary sessions feature expert presentations on how mobile technology and the internet are revolutionizing healthcare, the importance of newborn screening, big data, the biologic basis of obesity, and the latest advances that could lead to a cure for HIV. Six hundred and fifty exhibitors will be demonstrating displays of the latest diagnostic their technologies, including but not limited to automation, information systems, point-of-care (POC), and biotech.

Related Links:
World Health Organization
American Association of Clinical Chemistry



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.